Literature DB >> 12676926

Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73.

Christian Gaiddon1, Maria Lokshin, Isabelle Gross, Danielle Levasseur, Yoichi Taya, Jean-Philippe Loeffler, Carol Prives.   

Abstract

p73 transcription factors are members of the p53 family and participate in developmental processes and DNA damage response. p73 expression was shown to be regulated during the cell cycle, suggesting that p73 might play a role in cell growth and might be a target for cyclin-dependent kinases. Consistent with this hypothesis, we discovered that p73 interacts physically with various cyclins (A, B, D, and E). Furthermore, cyclin A/CDK1/2, cyclin B/CDK1/2, and cyclin E/CDK2 complexes can phosphorylate multiple p73 isoforms in vitro at threonine 86. A specific antibody directed against phosphorylated Thr86 showed that this site is phosphorylated in vivo and that such phosphorylation is regulated in a cell cycle-dependent manner. Thr86 phosphorylation is induced during S phase and is maximal in the G2/M phase. Accordingly inhibitors of cell growth, such as p16 and serum starvation, reduce Thr86 phosphorylation. Finally, we found that cyclin-dependent kinase (CDK)-dependent Thr86 phosphorylation represses the ability of p73 to induce endogenous p21 expression. Our results demonstrate that p73 proteins are targets of CDK complexes and that phosphorylation on Thr86 by CDKs regulates p73 functions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676926     DOI: 10.1074/jbc.M300251200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.

Authors:  Samir Benosman; Xiangjun Meng; Yannick Von Grabowiecki; Lavinia Palamiuc; Lucian Hritcu; Isabelle Gross; Georg Mellitzer; Yoichi Taya; Jean-Philippe Loeffler; Christian Gaiddon
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

Review 2.  Links between mutant p53 and genomic instability.

Authors:  Walter Hanel; Ute M Moll
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

3.  p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.

Authors:  Marshall Urist; Tomoaki Tanaka; Masha V Poyurovsky; Carol Prives
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

4.  Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation.

Authors:  Sarah Burge; Daniel P Teufel; Fiona M Townsley; Stefan M V Freund; Mark Bycroft; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

Review 5.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

Review 6.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

Review 7.  The p53 circuit board.

Authors:  Kelly D Sullivan; Corrie L Gallant-Behm; Ryan E Henry; Jean-Luc Fraikin; Joaquín M Espinosa
Journal:  Biochim Biophys Acta       Date:  2012-02-07

8.  Sp1 and p73 activate PUMA following serum starvation.

Authors:  Lihua Ming; Tsukasa Sakaida; Wen Yue; Anupma Jha; Lin Zhang; Jian Yu
Journal:  Carcinogenesis       Date:  2008-06-25       Impact factor: 4.944

Review 9.  p53 and metabolism.

Authors:  Karen H Vousden; Kevin M Ryan
Journal:  Nat Rev Cancer       Date:  2009-09-17       Impact factor: 60.716

10.  Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.

Authors:  Nami Koida; Toshinori Ozaki; Hideki Yamamoto; Sayaka Ono; Tadayuki Koda; Kiyohiro Ando; Rintaro Okoshi; Takehiko Kamijo; Ken Omura; Akira Nakagawara
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.